Skip to main content

Table 1 Patients characteristics, LOS and endpoints

From: Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital

   

Pre-LVAD phase days)

LVAD phase (days)

Total in-hospital stay (days)

End point

 

Patient #

Age (years)

Sex

LOS

ECMO LOS

LOS

LOS ICU

LOS

VA 1

64

M

20

 

22

25

42

Htx

VA 2

62

M

1

 

26

7

27

†

VA 3

15

F

8

 

26

6

34

Htx

VA 4

38

M

5

6

28

27

33

Htx

VA 5

23

M

8

 

32

10

40

Htx

VA 6

54

M

1

14

26

18

27

Htx †

VA 7

65

M

8

 

29

11

37

*

VA 8

16

F

15

23

42

13

57

*

VA 9

20

M

13

 

21

5

34

Htx

VA 10

59

M

14

 

88

35

102

†

VA 11

55

M

8

 

39

39

47

†

VA 12

53

F

12

 

32

21

44

Htx

VA 13

10

M

6

 

39

14

45

Htx

VA 14

19

M

49

 

42

17

91

Htx

VA 15

27

M

39

11

56

18

95

Htx

VA 16

29

M

2

 

125

56

127

Htx

VA 17

32

M

32

 

45

23

77

Htx

VA 18

21

M

44

 

25

14

69

Htx

VA 19

61

M

1

 

40

12

41

Htx

VA 20

16

M

8

4

4

12

12

Htx

HW 1

39

M

0

3

41

15

41

Htx

HW 2

72

M

5

 

42

21

47

Htx

HW 3

56

M

29

 

29

8

58

*

HW 4

62

F

11

 

31

12

42

†

HW 5

54

M

36

 

57

40

93

Htx

HW 7

61

M

6

7

27

9

33

Htx

HW 8

26

M

12

 

19

7

31

Htx

HW 10

35

M

17

 

40

6

57

Htx

HW 11

46

M

6

 

30

13

36

Htx

Mean

41

 

14

10

38

18

52

 

Range

(10-72)

 

(1-49)

(3-23)

(4-125)

(5-56)

(12-127)

 
  1. VA VentrAssist™LVAD.
  2. HW HeartWare™LVAD.
  3. M Male.
  4. F Female.
  5. LOS (Length of Stay) in days.
  6. ECMO Extra Corporeal Membrane Oxygenation.
  7. ICU Intensive Care Unit.
  8. Htx Heart transplantation.
  9. End points: † = dead, * = on device.
  10. ^^ patient no 6 and 9 from the HeartWare LVAD study was excluded as patient had HW BIVAD.
  11. **Mean cost for ECMO is only for the patients with ECMO.
Back to article page